当前位置:首页 - 行情中心 - 北陆药业(300016) - 财务分析 - 现金流量表

北陆药业

(300016)

  

流通市值:50.03亿  总市值:51.77亿
流通股本:5.62亿   总股本:5.82亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金367,006,602.031,201,156,280.74894,913,557.9583,292,154.33
  收到的税费返还3,576,447.836,901,631.486,590,593.86,590,593.8
  收到其他与经营活动有关的现金2,430,358.7323,744,722.0324,931,175.2321,060,617.81
  经营活动现金流入小计373,013,408.591,231,802,634.25926,435,326.93610,943,365.94
  购买商品、接受劳务支付的现金91,466,910.5481,409,219.46347,822,179.42258,569,238.77
  支付给职工以及为职工支付的现金66,547,567.8226,997,998.09172,178,181.88119,297,883.51
  支付的各项税费30,434,417.2483,074,449.6558,155,116.6135,129,228.17
  支付其他与经营活动有关的现金63,896,587.39283,752,937.3219,057,596.28140,906,242.62
  经营活动现金流出小计252,345,482.931,075,234,604.5797,213,074.19553,902,593.07
  经营活动产生的现金流量净额120,667,925.66156,568,029.75129,222,252.7457,040,772.87
二、投资活动产生的现金流量:
  收回投资收到的现金1,007,422.444,170,068.444,170,068.44137,038.79
  取得投资收益收到的现金5,574,435.320,264,316.4818,175,684.5115,695,470.62
  处置固定资产、无形资产和其他长期资产收回的现金净额-11,0009,0009,000
  收到的其他与投资活动有关的现金406,700,0001,269,100,000967,000,000643,500,000
  投资活动现金流入小计413,281,857.741,293,545,384.92989,354,752.95659,341,509.41
  购建固定资产、无形资产和其他长期资产支付的现金51,537,554.37218,872,538.99168,498,108.47110,539,984.36
  取得子公司及其他营业单位支付的现金-870,000--
  支付其他与投资活动有关的现金446,159,6001,321,186,400961,000,000690,000,000
  投资活动现金流出小计497,697,154.371,540,928,938.991,129,498,108.47800,539,984.36
  投资活动产生的现金流量净额-84,415,296.63-247,383,554.07-140,143,355.52-141,198,474.95
三、筹资活动产生的现金流量:
  取得借款收到的现金111,571,816518,678,138309,700,000271,000,000
  筹资活动现金流入小计111,571,816518,678,138309,700,000271,000,000
  偿还债务支付的现金53,000,000361,885,717.6164,793,217.6107,850,000
  分配股利、利润或偿付利息支付的现金3,378,714.7637,421,234.4734,073,236.2829,917,681.66
  支付其他与筹资活动有关的现金5,564,625.312,035,922.2910,100,193.426,362,912.22
  筹资活动现金流出小计61,943,340.06411,342,874.36208,966,647.3144,130,593.88
  筹资活动产生的现金流量净额49,628,475.94107,335,263.64100,733,352.7126,869,406.12
四、汇率变动对现金及现金等价物的影响-1,731,670.8-1,819,544.12-946,199.24-316,947.27
五、现金及现金等价物净增加额84,149,434.1714,700,195.288,866,050.6842,394,756.77
  加:期初现金及现金等价物余额231,767,897.8217,067,702.6217,067,702.6217,067,702.6
  期末现金及现金等价物余额315,917,331.97231,767,897.8305,933,753.28259,462,459.37
补充资料:
  净利润-88,648,072.01-26,937,220.9
  资产减值准备-13,339,579.74-4,261,684.82
  固定资产和投资性房地产折旧-82,057,739.66-40,568,768.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-82,057,739.66-40,568,768.64
  无形资产摊销-14,155,252.27-7,089,919.5
  长期待摊费用摊销-5,340,279.97-2,852,703.78
  处置固定资产、无形资产和其他长期资产的损失-1,229,172.24-1,266,134.62
  固定资产报废损失-639,768.73-277,972.03
  公允价值变动损失--53,436,304.56-855,712.62
  财务费用-41,170,506.72-27,537,146.77
  投资损失--8,067,847.7--990,763.49
  递延所得税-8,152,321.75--3,378,185.35
  其中:递延所得税资产减少--1,413,549.79-674,446.77
    递延所得税负债增加-9,565,871.54--4,052,632.12
  存货的减少--24,088,334.62--11,809,698.15
  经营性应收项目的减少--105,110,135.1--47,129,484
  经营性应付项目的增加-96,067,886.92-5,343,736.48
  其他--4,631,331.39-2,477,381.83
  融资租入固定资产-1,982,980.7--
  现金的期末余额-231,767,897.8-259,462,459.37
  减:现金的期初余额-217,067,702.6-217,067,702.6
  现金及现金等价物的净增加额-14,700,195.2-42,394,756.77
公告日期2026-04-292026-04-222025-10-292025-08-26
审计意见(境内)标准无保留意见
TOP↑